Hikma Pharmaceuticals PLC (LON:HIK)
London
· Delayed Price · Currency is GBP · Price in GBX 1,191.00
-18.00 (-1.49%)
At close: Mar 9, 2026
Hikma Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 217 | 188 | 205 | 270 | 426 | Upgrade
|
| Trading Asset Securities | - | 25 | 24 | 22 | 24 | Upgrade
|
| Cash & Short-Term Investments | 217 | 213 | 229 | 292 | 450 | Upgrade
|
| Cash Growth | 1.88% | -6.99% | -21.57% | -35.11% | 29.68% | Upgrade
|
| Accounts Receivable | 1,061 | 896 | 789 | 777 | 781 | Upgrade
|
| Other Receivables | 18 | 77 | 84 | 64 | 95 | Upgrade
|
| Receivables | 1,079 | 973 | 873 | 841 | 876 | Upgrade
|
| Inventory | 1,106 | 986 | 891 | 776 | 695 | Upgrade
|
| Prepaid Expenses | - | 73 | 72 | 74 | 65 | Upgrade
|
| Other Current Assets | 241 | 18 | 35 | 16 | 8 | Upgrade
|
| Total Current Assets | 2,643 | 2,263 | 2,100 | 1,999 | 2,094 | Upgrade
|
| Property, Plant & Equipment | 1,448 | 1,326 | 1,141 | 1,081 | 1,146 | Upgrade
|
| Long-Term Investments | 11 | 62 | 65 | 52 | 46 | Upgrade
|
| Goodwill | 393 | 382 | 388 | 389 | 285 | Upgrade
|
| Other Intangible Assets | 777 | 774 | 712 | 735 | 607 | Upgrade
|
| Long-Term Deferred Tax Assets | 307 | 293 | 226 | 192 | 183 | Upgrade
|
| Other Long-Term Assets | 92 | 33 | 48 | 23 | 11 | Upgrade
|
| Total Assets | 5,671 | 5,133 | 4,680 | 4,471 | 4,372 | Upgrade
|
| Accounts Payable | 715 | 358 | 309 | 291 | 262 | Upgrade
|
| Accrued Expenses | - | 439 | 388 | 272 | 305 | Upgrade
|
| Short-Term Debt | 14 | 21 | 46 | 75 | 64 | Upgrade
|
| Current Portion of Long-Term Debt | 92 | 621 | 104 | 64 | 48 | Upgrade
|
| Current Portion of Leases | 8 | 11 | 11 | 9 | 9 | Upgrade
|
| Current Income Taxes Payable | 74 | 78 | 74 | 73 | 57 | Upgrade
|
| Current Unearned Revenue | - | 28 | 21 | 193 | 213 | Upgrade
|
| Other Current Liabilities | 550 | 422 | 386 | 100 | 58 | Upgrade
|
| Total Current Liabilities | 1,453 | 1,978 | 1,339 | 1,077 | 1,016 | Upgrade
|
| Long-Term Debt | 1,445 | 607 | 975 | 1,074 | 651 | Upgrade
|
| Long-Term Leases | 45 | 46 | 55 | 61 | 74 | Upgrade
|
| Long-Term Unearned Revenue | - | 30 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 16 | 18 | 25 | 19 | 24 | Upgrade
|
| Other Long-Term Liabilities | 106 | 133 | 77 | 92 | 140 | Upgrade
|
| Total Liabilities | 3,065 | 2,812 | 2,471 | 2,323 | 1,905 | Upgrade
|
| Common Stock | 40 | 40 | 40 | 40 | 42 | Upgrade
|
| Additional Paid-In Capital | 282 | 282 | 282 | 282 | 282 | Upgrade
|
| Retained Earnings | 2,556 | 2,362 | 2,158 | 2,092 | 2,189 | Upgrade
|
| Comprehensive Income & Other | -285 | -374 | -282 | -279 | -60 | Upgrade
|
| Total Common Equity | 2,593 | 2,310 | 2,198 | 2,135 | 2,453 | Upgrade
|
| Minority Interest | 13 | 11 | 11 | 13 | 14 | Upgrade
|
| Shareholders' Equity | 2,606 | 2,321 | 2,209 | 2,148 | 2,467 | Upgrade
|
| Total Liabilities & Equity | 5,671 | 5,133 | 4,680 | 4,471 | 4,372 | Upgrade
|
| Total Debt | 1,604 | 1,306 | 1,191 | 1,283 | 846 | Upgrade
|
| Net Cash (Debt) | -1,387 | -1,093 | -962 | -991 | -396 | Upgrade
|
| Net Cash Per Share | -6.23 | -4.89 | -4.33 | -4.41 | -1.70 | Upgrade
|
| Filing Date Shares Outstanding | 220.8 | 220.43 | 221.08 | 220.24 | 231.5 | Upgrade
|
| Total Common Shares Outstanding | 220.8 | 220.43 | 221.08 | 220.24 | 231.5 | Upgrade
|
| Working Capital | 1,190 | 285 | 761 | 922 | 1,078 | Upgrade
|
| Book Value Per Share | 11.74 | 10.48 | 9.94 | 9.69 | 10.60 | Upgrade
|
| Tangible Book Value | 1,423 | 1,154 | 1,098 | 1,011 | 1,561 | Upgrade
|
| Tangible Book Value Per Share | 6.44 | 5.24 | 4.97 | 4.59 | 6.74 | Upgrade
|
| Land | - | 851 | 797 | 725 | 676 | Upgrade
|
| Machinery | - | 1,067 | 1,042 | 964 | 934 | Upgrade
|
| Construction In Progress | - | 409 | 272 | 262 | 271 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.